Suppression of Indoleamine 2,3‐Dioxygenase Enhances Immune Responses to the Therapeutic Vaccine for Chronic Hepatitis B
The clinical trial was registered in the UMIN Clinical Trials Registry (no. UMIN000027442) and the Japan Registry of Clinical Trials (no. jRCTs061180100).
Authors
- Ayumu Kanbe (ORCID: https://orcid.org/0000-0003-2257-5676)
- Masahito Shimizu (ORCID: https://orcid.org/0000-0002-1151-2058)
- Hiroyasu Ito (ORCID: https://orcid.org/0000-0002-4836-4001)
- Soranobu Ninomiya (ORCID: https://orcid.org/0000-0003-2583-0513)
- Takayasu Ideta (ORCID: https://orcid.org/0009-0008-6409-2289)
- Hiroyasu Sakai (ORCID: https://orcid.org/0000-0002-2767-9063)
- Toshihide Maeda
- Yohei Shirakami (ORCID: https://orcid.org/0000-0002-2471-090X)
- Masaya Kubota
- Daisuke Minowa
- Yoichi Hiasa
- Osamu Yoshida
- Kenji Imai
- Kuniaki Saito
- Yasuko Yamamoto
- Daisuke Taguchi
Institutions
- Fujita Health University (JP)
- Gifu University Hospital (JP)
- Fujita Health University Hospital (JP)
- Saitama International Medical Center (JP)
- Ehime University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1111/hepr.70165
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00